🟢 Opus Genetics is trading 5% up today amid a biotech sector rally

Opus Genetics is trading at $4.21, up 5.24%, in a move that appears primarily sector-driven, alongside a broader market rebound.

• The XBI biotech benchmark is up 2.01% in the regular session.
• No clear company-specific announcement on November 6 explains the gain. On November 5, Opus Genetics announced it completed dosing in Cohort 2 of its OPGx-BEST1 trial; topline data is expected in Q1 2027.